12 July 2019 Blog Post: PrEP (a daily pill to prevent HIV infection termed pre-exposure prophylaxis)

In most cases a report showing that the use of a particular medication has soared 500% would not be good news. However, in the case of PrEP (a daily pill to prevent HIV infection termed pre-exposure prophylaxis) this is welcome finding. More than a third of people at risk of HIV infection are now protected with the medication, which is more than 90% effective, according to a CDC report published today.

Some of my patients may already know that my interest in medicine first germinated in the early 1990s when I spent the better part of a year working at the Fenway Community Health Center in Boston while an undergraduate. There I worked on two HIV/AIDS studies and never imagined a time when there would be a effective treatment, much less a mechanism that could end HIV.

By routinely testing patients for HIV, assessing HIV-negative patients for risk behaviors, and prescribing PrEP as needed, health care providers can play a critical role in ending the HIV epidemic. Dr. Kenneth Mayer (who oversaw the studies I had the good fortune to work on while at Fenway) has been a tremendous advocate for PrEP. His article in JAMA in 2018 (linked below) highlights this 90% efficacy.

My patients who take PrEP already know (since I tell them) that it is “my favorite medication to prescribe.”

𝗦𝗢𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 π—’π˜‚π—Ώ π—‘π—²π˜„π˜€π—Ήπ—²π˜π˜π—²π—Ώ

Dig deeper into the health topics you care about most by signing up for our newsletter.

by submitting this form you indicate you have
read and agree to our Privacy Policy and Terms
of Use. Please contact us to for us for more

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *